InvestorsHub Logo
Followers 25
Posts 1059
Boards Moderated 0
Alias Born 12/20/2008

Re: None

Monday, 11/29/2010 10:18:02 AM

Monday, November 29, 2010 10:18:02 AM

Post# of 186

Chem Rx Lost Exclusive Plan-Filing Right to Committee

Chem Rx Corp., which had been the third-largest provider of institutional pharmacy services in the U.S., lost the exclusive right to propose a liquidating Chapter 11 plan.

Last week the bankruptcy court in Delaware gave the creditors’ committee and the first-lien lenders the right to file a plan jointly. Except for the committee and the lenders, Chem Rx’s exclusive right to propose a plan was extended to Jan. 31.

The business was sold to PharMerica Corp., the operator of 90 institutional pharmacies in 41 states. It paid $70.6 million plus the assumption of specified liabilities. PharMerica was the so-called stalking horse at auction.

Chem Rx, which changed its name to CRC Parent Corp. following the sale, filed under Chapter 11 in May after first- lien lenders owed $103 million were seizing the Long Beach, New York-based company’s income. The first-lien debt had been in default since early 2009.

Other liabilities include $37 million owing on a second- lien and $8.3 million in subordinated debt owing to affiliates of insiders. CIBC World Markets Corp. is agent for the lenders on the first- and second-lien loans. The petition listed assets of $170 million against debt totaling $178 million.

The case is In re CRC Parent Corp., 10-11567, U.S. Bankruptcy Court, District of Delaware (Wilmington).



http://www.bloomberg.com/news/2010-11-29/lehman-trico-mesa-air-chem-rx-old-gm-workflow-bankruptcy.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.